Opioid substitution to reduce adverse effects in cancer pain management-Reference-Cited by-同舟云学术

Opioid substitution to reduce adverse effects in cancer pain management

Published:1999-01 Issue:2 Volume:170 Page:68-71
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Ashby Michael A¹,Martin Peter¹,Jackson Kate A¹

Affiliation:

1. McCulloch House, Monash Medical Centre, and Department of Medicine, Monash UniversityMelbourneVIC

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.1999.tb126885.x

Reference19 articles.

1. Department of Health and Human Services.Public Health Services.Agency for Health Care Policy and Research. Clinical Practice Guideline Number 9. Management of cancer pain.Rockville (MD): AHCPR Publication No. 94‐0592 1994.

2. GlareP.Side effects of morphine in patients being treated for chronic pain due to advanced cancer.Australian Pain Society 18th Annual Scientific Meeting.Ayers Rock Australia 1997.

3. Individual variability in the response to different opioids: report of five cases

4. Opioid rotation for toxicity reduction in terminal cancer patients

5. Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for developing μ opioid receptor agonists with reduced adverse effects;Bioorganic Chemistry;2024-08

2. Evolution and challenges of opioids in pain management: Understanding mechanisms and exploring strategies for safer analgesics;Medicinal Chemistry Research;2024-02-29

3. Chronic cancer pain syndromes and their treatment;Neurological Complications of Systemic Cancer and Antineoplastic Therapy;2022

4. Analgetika;Arzneimitteltherapie in der Palliativmedizin;2022

5. Opioid Analgesia and Opioid-Induced Adverse Effects: A Review;Pharmaceuticals;2021-10-27